150 related articles for article (PubMed ID: 38702737)
1. Incorporating clinician insight and care plans into an audit and feedback initiative for antipsychotic prescribing to Medicaid-enrolled youth in Philadelphia.
Candon M; Shen S; Rothbard A; Reed A; Everett M; Demp N; Weingartner M; Fadeyibi O
BMC Health Serv Res; 2024 May; 24(1):574. PubMed ID: 38702737
[TBL] [Abstract][Full Text] [Related]
2. The impact of opioid prescribing report cards in Medicaid.
Candon M; Xue L; Shen S; Cole ES; Donohue J; Rothbard A
J Manag Care Spec Pharm; 2022 Aug; 28(8):862-870. PubMed ID: 35876292
[No Abstract] [Full Text] [Related]
3. Trends in antipsychotic prescribing for approved and unapproved indications to Medicaid-enrolled youth in Philadelphia, Pennsylvania between 2014 and 2018.
Candon M; Shen S; Fadeyibi O; Smith JL; Rothbard A
BMC Psychiatry; 2021 Oct; 21(1):524. PubMed ID: 34686159
[TBL] [Abstract][Full Text] [Related]
4. Use of Academic Detailing With Audit and Feedback to Improve Antipsychotic Pharmacotherapy.
Brunette MF; Cotes RO; de Nesnera A; McHugo G; Dzebisashvili N; Xie H; Bartels SJ
Psychiatr Serv; 2018 Sep; 69(9):1021-1028. PubMed ID: 29879874
[TBL] [Abstract][Full Text] [Related]
5. Trends Over Time in Antipsychotic Initiation at a Large Children's Health Care System.
Chavez LJ; Kelleher KJ; Beck A; Clarke GN; Penfold RB
J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):381-386. PubMed ID: 34143677
[No Abstract] [Full Text] [Related]
6. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
[TBL] [Abstract][Full Text] [Related]
7. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
[TBL] [Abstract][Full Text] [Related]
8. The implementation of opioid prescribing report cards in Medicaid managed care: a community quality collaborative.
Shen S; Candon M; Fadeyibi O; Kaplan K; Lim S; Mandell DS; Neimark G; Olubiyi O; Pizzicato LN; Tjoa C; Washington R; Rothbard A
Am J Manag Care; 2021 Dec; 27(12):e429-e434. PubMed ID: 34889586
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals.
Morrato EH; Campagna EJ; Brewer SE; Dickinson LM; Thomas DS; Miller BF; Dearing J; Druss BG; Lindrooth RC
JAMA Psychiatry; 2016 Jul; 73(7):721-30. PubMed ID: 27167755
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
Dimitropoulos E; Drogemuller L; Wong K
J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
[TBL] [Abstract][Full Text] [Related]
12. Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based Aid.
Leckman-Westin E; Finnerty M; Scholle SH; Pritam R; Layman D; Kealey E; Byron S; Morden E; Bilder S; Neese-Todd S; Horwitz S; Hoagwood K; Crystal S
J Manag Care Spec Pharm; 2018 Mar; 24(3):238-246. PubMed ID: 29485947
[TBL] [Abstract][Full Text] [Related]
13. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.
Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM
J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230
[TBL] [Abstract][Full Text] [Related]
14. Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain.
Crystal S; Mackie T; Fenton MC; Amin S; Neese-Todd S; Olfson M; Bilder S
Health Aff (Millwood); 2016 Jun; 35(6):974-82. PubMed ID: 27269012
[TBL] [Abstract][Full Text] [Related]
15. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages.
Kogut SJ; Yam F; Dufresne R
J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
17. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
18. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
Melvin KE; Hart JC; Sorvig RD
Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
[TBL] [Abstract][Full Text] [Related]
19. Incident users of antipsychotics: who are they and how do they fare?
Baandrup L; Kruse M
Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887
[TBL] [Abstract][Full Text] [Related]
20. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
